While systemic and endothelial-specific PHD2 inhibition attenuates obesity and metabolic dysfunction in mice, we also noticed that several aged PHD2 ECKO mice died during the study, indicating a detrimental effect of endothelial-specific PHD2 inhibition on the life span. Here, EGLN1 is linked to obesity disorder.